One Thousand Three Hundred and Forty-Seven Had to Guard Against

"Huh? Why conduct clinical trials in China?"

Xiao Feng was also taken aback when he heard this, because many of the drugs they developed before were all conducted clinical trials in India.

On the one hand, it is because it is easy to find people to conduct clinical trials there, and the cost is very low.

Because the cost is low, more people can be found, experiments can be carried out at the same time, and more data can be collected.

In this way, the cycle of drug development can be greatly shortened.

Now almost all major pharmaceutical companies in Europe and the United States have established clinical research and development centers in Indiana.

And not only in India, some have opened clinical trial centers in Africa.

At present, because of the distance, the Ninth Laboratory has no plans to open a clinical research center in Africa.

But the clinical research center on the Indian side is a piece that they value very much.

This time, He Fangzhou and the others came up with some kind of NMD+ drug, which has already seen obvious curative effect on mice.

But human experiments still had to be done, Xiao Feng originally thought that they would go to India to do experiments as usual and forget it.

Unexpectedly, this time they actually planned to conduct clinical trials in China.

However, if clinical trials are carried out in China, the cost will be high.

The shortest period is six years, and the cost of recruiting volunteers for the experiment will be very high.

The most important thing is that if you are not careful, you will easily get into a lawsuit, and there is a very high legal risk.

And the explanation given by He Fangzhou and the others surprised Xiao Feng very much.

"Actually, Mr. Xiao, the health-care effect of this drug is now clear to us."

"If this drug is only marketed as a health product, it must be very simple, and there is no need to do various clinical trials at all."

"We just need to prove that this supplement is non-toxic and has no side effects."

"But the reason why we want to launch clinical trials is because we think this coenzyme I still has a lot of potential to be tapped."

"For example, his first effect is to accelerate the production of metabolic compounds. We think that it can be used as a drug alone, and it can have obvious curative effects on many metabolic diseases, such as thyroid diseases."

"In addition, what we value most is that he has the special effect of repairing DNA. We want to strengthen his effect in this area, so we need to do more clinical trials. Once this experiment is successful. Then many diseases that plagued us before, It will heal itself without attacking."

"For example, leukemia, such as tumors, and so on, are all diseases related to gene mutations."

"We even plan to see if taking this coenzyme I early can effectively prevent the above diseases?"

After hearing what He Fangzhou said, Xiao Feng understood why they planned to carry out research in this area in China.

Although conducting such clinical trials in China will be time-consuming and costly.

But most importantly, data security can be guaranteed.

Although the cost of conducting clinical trials in India is low, considering that things will happen every now and then.

Therefore, it is better to put such an important experiment in China.

Especially now that their ninth laboratory can be said to have a very good reputation.

And it has attracted considerable attention on the Indian side.

In fact, Xiao Feng was not too scared when another overseas giant set up a laboratory in Indiana.

Instead, he was afraid of those native Indians.

You must know that Indian has another nickname, that is World Pharmacy!

It is said that their level of generic drugs is very high.

Many very expensive and very difficult drugs, as soon as they are on the market, they will be able to copy them in a short time.

This has caused many large pharmaceutical companies in the world to feel a headache.

Even for this matter, he has filed a lawsuit with them many times. ,

But the final result is that those world-class giants,

Didn't get any benefits in Indian.

Indian generic drug companies are still providing cheap and practical drugs to people all over the world.

And as early as the Ninth Laboratory became famous, the generic pharmaceutical companies in India also wanted to imitate their drugs.

In other words, not only Indian pharmaceutical companies, but pharmaceutical companies all over the world have tried to imitate their drugs.

But the problem is that the key raw materials in several of their drugs are not from this world.

It was brought back by Xiao Feng from another world, such as small molecule collagen, and K-alpha factor, or the venom of the snake man, etc.

These drugs are not products of this planet, so no matter how powerful these pharmaceutical companies are, they still have to face a problem that a smart woman can't live without rice.

And those world-class giants still need some face.

Even if they want to imitate the medicine of the Ninth Laboratory, it is done quietly in secret.

Few dare to blatantly imitate.

But Indian pharmaceutical companies are different. Because of the protection of their country's laws, they can blatantly and unscrupulously carry out imitation.

Sometimes even because they don't understand the principle, they even dare to send people to the clinical research laboratories set up by other pharmaceutical companies in India to steal other people's research and development data.

Don't think you are joking at this time, this is what actually happened.

And those pharmaceutical companies can only do nothing about this situation.

Who told them to set up clinical laboratories on other people's territory.

Although the data will be stolen every now and then, they still stick to this land.

why? The reason is simple, because the cost here is too low.

For example, if you bring a living person to conduct an experiment, if it is in their home country of Europe and America.

Not only do you have to be responsible for the various expenses of others, but you also have to pay a high salary, which normal people would agree to.

And even if it is a disease patient, although it is said to be a recruited volunteer, you have to give various hidden benefits before they will agree.

And in India, hehe, five dollars can bring a large living person, and a healthy person will come to participate in your experiment.

As for those who are already sick, they simply don't need money.

So you said those pharmaceutical companies, will they leave because of that data?

Of course, they will eventually sign an agreement with Indian. Even if Indian produces generic drugs, they are not allowed to sell them in the local market of these pharmaceutical companies.

It is not allowed to grab the market internationally, and it is only allowed to be sold in India, and it is not allowed to be sold overseas before the patent protection expires.

Of course, some people can also use human flesh to buy medicines in India.

But these are petty profits, and they will not hurt the foundation of those big pharmaceutical companies at all.

The clinical laboratory established by the Ninth Laboratory in Indiana had been burglarized several times before.

It seems that small thieves go inside to steal things, but in fact they all go for their experimental clinical data.

Fortunately, Xiao Feng and the others had already made preparations for such a thing.

The data is uploaded to the company's server in real time every day, and part of it is destroyed. Even if the remaining part is left, it is deliberately left with wrong data to mislead plagiarists.

So until now, the Indians have not been able to get any cheap from them.

But going on like this is definitely not a long-term solution, after all, those guys are notoriously fond of playing tricks.

It can be seen from the fact that they have been driven out one after another in the recent period.

There are also undercurrents surging in their country now, and the political struggle is very fierce.

Although he doesn't have the strength of the world's boss, he has learned the shortcomings of the boss, and he likes to do something to divert the attention of ordinary people in China.

So it's not very peaceful recently.

Moreover, Xiao Feng also felt that he had to guard against this group of Indians who often betrayed their promises.

He Fangzhou and the others don't plan to put the most important experiments there, which is very normal.

Otherwise, if one day the results are about to come out and they give you a stick, it will be bad.

Xiao Feng also understood that He Fangzhou and the others planned to use this NMD+ as the base material to develop new drugs for various diseases.

For example, emphasizing the first characteristic, the characteristic of accelerating metabolism, and developing drugs for chronic metabolic diseases based on this.

Or emphasize the characteristics of DNA repair, and use this to develop drugs that can target diseases caused by genetic mutations such as leukemia and tumors.

Their idea is very good, but such an important experiment really can't be put in Indian.

It is really suitable to put it in the country.

However, this kind of clinical trial has a long cycle and a large investment in China. It is estimated that several billion will be invested in a few years.

With such a large investment, they naturally want to say hello to themselves first.

"Well, I will do it according to your wishes. Now that the number of leukemia children in China is increasing rapidly, I also hope that you can develop anti-leukemia drugs as soon as possible."

Xiao Feng nodded in agreement, He Xiaojun and He Fangzhou nodded vigorously.

"Thank you Mr. Xiao for your support."

"Well, by the way, if this drug is marketed as a health product, how do you plan to promote it?"

Although the Ninth Laboratory is now famous all over the world, and it still holds such a global sales channel as Voegelin in its hands.

But if you want to launch such a new product, it is not easy to succeed.

After all, there are already NMN pearls and jade in front, and although this NMD+ is more effective, the price is definitely not cheap.

So Xiao Feng really wanted to know how He Xiaojun and the others planned to make this NMD+ famous.

"Hey, it's not easy. Our plan is to let Mr. He publish articles in journals like Nature or The Lancet!"

"In the name of Mr. He, if you submit to these two journals, you will be admitted every minute."

"As long as these two articles are published, it will cause heated discussions in the academic circle. Hehe, once the product is launched, it will not be afraid that no one will buy it..."